A male aged 40 years presenting with papillary cancer thyroid confined to one lobe of thyroid of size 3×3 cm with no node palpable. What is the ideal treatment?
First, I need to recall the standard treatment protocols for papillary thyroid cancer. Papillary thyroid cancer is the most common type of thyroid cancer. The main treatment is usually surgery. The extent of surgery depends on the tumor's stage and characteristics.
The tumor here is in one lobe, 3 cm in size. The options would likely include lobectomy versus total thyroidectomy. For papillary carcinoma, guidelines from organizations like the American Thyroid Association (ATA) suggest that for tumors ≤4 cm with no evidence of extrathyroidal extension or lymph node involvement, a lobectomy with isthmusectomy might be sufficient. However, some guidelines recommend total thyroidectomy for better monitoring and ease of radioactive iodine ablation if needed.
Wait, but let me check the staging. The size is 3 cm, which is stage I if the patient is under 45 years old. Stage I papillary thyroid cancer typically has a lobectomy as the primary treatment. Since the patient is 40, stage I, and no nodes, lobectomy would be appropriate. Total thyroidectomy might be considered if there's a high risk of recurrence or if there's a family history of medullary thyroid cancer, but that's not mentioned here.
The options aren't listed, but the correct answer is likely lobectomy. So the wrong options could be total thyroidectomy, radiation, or chemotherapy. Lobectomy is the standard here because it's a low-risk, small tumor confined to one lobe. Total thyroidectomy is more for larger tumors, extrathyroidal extension, or high-grade tumors. Radiation isn't typically first-line unless there's residual disease. Chemotherapy is not a first-line treatment for papillary thyroid cancer.
So, the core concept is the surgical management of papillary thyroid cancer. The correct answer is lobectomy. The other options are either for more advanced cases or not standard first-line treatments. The clinical pearl is that for small, low-risk papillary thyroid cancers, lobectomy is sufficient, avoiding unnecessary total thyroidectomy which can lead to lifelong hormone replacement.
**Core Concept** Papillary thyroid carcinoma (PTC) is the most common thyroid malignancy. Treatment depends on tumor size, extent, and patient age. The American Thyroid Association (ATA) classifies tumors ≤4 cm confined to one lobe in patients 4 cm), extrathyroidal extension, or high-risk features.
**Option C:** Radioactive iodine is used post-surgery for residual disease control or high-risk cases, not as primary treatment.
**Option